tweetindex
TR

MHRAgovuk

@MHRAgovuk · United Kingdom · joined 07 Jul 2011

We want our social channels to be safe spaces for healthy, open and insightful discussion. Please read our community guidelines here https://t.co/vloFQ9oujb

30 157Followers
559Following
5 661Posts total
6.6KViews on collected posts

Son gönderiler

@MHRAgovuk I use AI to re-engineer all timelines of products???? Dual-mode microwave/plasma stabilization lines for Tex-PAN precursors targeted at wind turbine spar caps and Type IV composite pressure vessel??? This is just one simple idea 15 views · 0 likes · 0 reposts · 0 replies Open on X →
AI has the potential to support new approaches to healthcare, from prevention and earlier intervention to more personalised care. In the second film from our series, hear perspectives on the opportunities AI could create across health and care. 🔗 https://t.co/lKqiylsYLi https: 1.7K views · 2 likes · 0 reposts · 4 replies Open on X →
AI in healthcare is advancing quickly – and regulation must keep pace. 📽️ Hear voices from healthcare, industry, academia and government on why the National Commission’s work to inform a future AI regulatory framework that is safe, fast and trusted matters now https://t.co/67mhX 1.1K views · 6 likes · 2 reposts · 4 replies Open on X →
🎤The MHRA has launched a public consultation on proposals to update its statutory fees from 1 April 2027. Read the consultation and share your views. https://t.co/YSRj5uQ5Es #MHRA #LifeSciences #Regulation #Consultation #HealthcareInnovation #MedicalDevices #Medicine https://t.co 1.1K views · 4 likes · 0 reposts · 0 replies Open on X →
☀️ Taking medication this summer? Some medicines can make you more sensitive to the sun, increase the risk of dehydration, or affect how your body copes with heat. Find out more: https://t.co/tCugyCnZxY #SummerProofYourHealth https://t.co/0TOMSvtnyD 1.1K views · 4 likes · 4 reposts · 1 replies Open on X →
🔁Faster access to treatments, without compromising safety. Our approval of aficamten this week, alongside NICE, marks an important milestone for patients with obstructive hypertrophic cardiomyopathy, made possible through strengthened collaboration across the health system. 1.6K views · 3 likes · 0 reposts · 5 replies Open on X →

Aynı büyüklükteki hesaplara karşı

Son 90 güne ait 6 gönderi, 10K–100K takipçi aralığıyla yan yana. boyutuna göre olağan erişim, çoğundan daha zayıf tepki.

Medyan görüntülenme1 110bu hesap92410K–100K için medyan
Erişim, %3.68%bu hesap3.62%10K–100K için medyan
Etkileşim, %0.46%bu hesap1.52%10K–100K için medyan
ÖlçütBu hesap10K–100K için medyanOran
Gönderi başına medyan görüntülenme1 1109241.20×
Erişim (görüntülenme ÷ takipçi)3.68%3.62%1.02×
Etkileşim oranı0.46%1.52%0.30×

Bu aralıktaki diğer hesaplar →   Başka bir hesapla karşılaştır →   Bu kıyas değerleri nasıl kuruluyor →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

1.6K31 Jul
1.1K10 Aug
1.1K17 Aug
1.1K21 Aug
1.7K26 Aug
1527 Aug

Last 6 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.51%31 Jul
0.79%10 Aug
0.37%17 Aug
1.20%21 Aug
0.41%26 Aug
0.00%27 Aug

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.52%.

What the audience does

Likes45.2%19 in total
Reposts14.3%6 in total
Replies33.3%14 in total
Quotes4.8%2 in total
Bookmarks2.4%1 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Benzer hesaplar